Related Experiment Video
Updated: Jul 15, 2025
10:03
Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
Published on: November 11, 2016
9.9K
Application of Induced Pluripotent Stem Cells in Malignant Solid Tumors
Rong He1, Zhijie Weng1, Yunkun Liu1
1State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
Stem Cell Reviews and Reports
|September 27, 2023
Summary
Induced pluripotent stem cells (iPSCs) offer new avenues for malignant solid tumor research, from modeling to novel therapies. This review explores iPSC applications and challenges in cancer treatment.
Area of Science:
- Oncology
- Stem Cell Biology
- Regenerative Medicine
Background:
- Malignant solid tumors remain a significant challenge with unsatisfactory treatment outcomes.
- Induced pluripotent stem cells (iPSCs) technology has advanced, offering new tools for biological research.
- Reprogramming techniques in iPSCs can influence cell fate, relevant to cancer biology.
Purpose of the Study:
- To review the evolution and applications of induced pluripotent stem cells (iPSCs) in malignant solid tumor research.
- To explore the potential of iPSCs in cancer modeling, cell therapy, and immunotherapy.
- To discuss the challenges and future directions of iPSC technology in oncology.
Main Methods:
- Literature review of induced pluripotent stem cells (iPSCs) applications in cancer research.
- Analysis of studies utilizing iPSCs derived from various sources (somatic cells, tumors, etc.).
- Synthesis of information on iPSC-based cancer modeling, therapy, and progression studies.
Main Results:
- Induced pluripotent stem cells (iPSCs) show significant potential in modeling various aspects of malignant solid tumors.
- iPSC technology is being explored for innovative cell therapies and immunotherapies against cancer.
- Studies highlight the utility of iPSCs in understanding tumor progression and patient-specific disease mechanisms.
Conclusions:
- Induced pluripotent stem cells (iPSCs) represent a promising frontier in advancing malignant solid tumor research and therapeutic strategies.
- Overcoming technical and ethical obstacles is crucial for the clinical translation of iPSC-based cancer treatments.
- The integration of iPSC technology holds potential to revolutionize the approach to treating malignant solid tumors.
Keywords:
Cancer cell reprogrammingCancer stem cellImmunotherapyInduced pluripotent stem cellsMalignant solid tumorsMore Related Videos
10:57Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
Published on: October 24, 2019
10.4K
05:08Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
Published on: February 17, 2019
6.2K
Related Concept Videos
01:06Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
01:22iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
01:19Mesenchymal Stem Cells
4.8K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
01:17Stem Cell Culture
5.2K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.2K